News
18h
TipRanks on MSNGilead Sciences Advances HIV-1 Treatment with New Clinical Study on GS-3242
Gilead Sciences (($GILD)) announced an update on their ongoing clinical study. Gilead Sciences is currently recruiting participants for a clinical ...
11h
Rough Draft Atlanta on MSNCVS Health withholds coverage for new HIV prevention drug
CVS Health, one of the nation’s largest pharmacy benefit manager companies that play a lead role in deciding which drugs are ...
South Africa is among the first countries in line to receive doses of lenacapavir, the six-monthly injection for HIV prevention. According to national health department projections, the country could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results